In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Pulsed Field Ablation (PFA) Summit 2026

11 April from 8:30 to 17:30 at the Palais des Congres - Porte Maillot - Paris

 

PFASummit2026-Visuel-web.jpg

What is the PFA Summit?

The 'PFA Summit: From Bench to Bedside' offers a unique full-day deep dive into this innovation’s trajectory—bridging foundational biophysics, emerging device engineering, and the practical realities of contemporary EP workflows. 

This Summit aims to:

  • Illuminate the scientific principles and selective cellular mechanisms of PFA
  • Showcase engineering breakthroughs in catheter and waveform design
  • Analyse pivotal trials and early clinical implementation
  • Debate regulatory and educational hurdles for broader adoption
  • Explore PFA’s transformative potential for AF ablation and other arrhythmias

Whether you're an electrophysiologist, biomedical engineer, healthcare policymaker, or industry innovator—this is your opportunity to engage with the pulse of the future.

“The world of PFA is evolving so rapidly that we felt compelled to offer a structured, high-impact journey—covering biophysical foundations, device technologies, and the most current clinical insights.”Prof. Serge Boveda & Dr. Atul Verma - PFA Summit Directors

The PFA Summit will take place on Saturday, 11 April from 8:30 to 17:30 at the Palais des Congres - Porte Maillot, level 3.

The EHRA PFA Summit 2026 is a co-organised initiative of:

  • The European Heart Rhythm Association (EHRA), a branch of the ESC
  • The Canadian Heart Rhythm Society (CHRS)

The Summit programme will be submitted to UEMS for accreditation.

How to register

Registration is open to all EHRA delegates. Registration is proposed as an add-on event to your EHRA Congress registration and is open on a first-come first-served basis.

PFA Summit registration includes:

  • Access to all sessions during the full-day conference event
  • Permanent coffee break & finger food lunch
  • Video on demand until 27 April 2026

Registration fees

Early fee until 12 February: €100
Late fee until 12 March: €125
From 13 March: €150

 

I want to register now

I want to register a group

Registration terms and conditions

Scientific programme

The EHRA PFA Summit 2026 will be divided into two parts, designed to build upon each other:

Part 1 – Morning Session: Technology & Foundations
  • The science and selectivity of electroporation
  • Comparative overview of PFA devices and waveforms
  • Technical innovations in catheter design
  • Mapping integration and procedure workflows

 

Session 1: The Basics of Pulsed Field Ablation

Chairs: D Miklavčič, A Verma, S Boveda

8:30 Covering the basics of Pulsed Field Ablation – electroporation of cell membrane - L Rems

8:45 Tissue response to Pulsed Field Ablation – pulse delivery - A Ivorra

9:00 Tissue Selectivity of Pulsed Field Ablation – how selective is it? – K Neven

9:15 Q&A Panel – 20 min

 

Session 2: Applying basics to clinical application

Chairs: D Miklavčič, A Verma, S Boveda

9:50 Choosing the right waveform and catheter – D Miklavčič

10:05 Predicting the lesion size – B Kos

10:20 Understanding/Managing PFA Problems – A Verma

10:35 Q&A Panel – 20 min

 

Session 3: Pulsed Field Ablation in the future

Chairs: D Miklavčič, A Verma, S Boveda

11:10 Learning from the others – other biomedical applications (cancer) – J Gehl

11:25 Defining endpoints in Pulsed Field Ablation – M Terricabras

11:40 Future directions for Pulsed Field Ablation – J Koruth

11:55 Q&A Panel - 20 min

 

Part 2 – Afternoon Session: Clinical Evidence & Application
  • Latest results from pivotal trials and registries
  • Real-world experience: successes and challenges

 

Session 1: Bridging pulsed field ablation evidence and action: what do the latest clinical trials mean for practice?

Chairs: A Sultan, J Andrade

13:15 BEAT-AF: an insider's view - P Jaïs

13:23 Understanding single-shot champion: Insights from post-hoc analyses - Tobbias Reichlin

13:31 FACIL-AF trial: French contributions to pulsed field ablation - P Defaye

13:39 Pulsed field ablation and regulatory trials: navigating investigational device exemption and global approval pathways - A Anic

13:47 What do global registries tell us? lessons from the real life - V Reddy

13:55 Round Table: clinical pulsed field ablation

 

Session 2: Pulsed Field Ablation in the lab: Lessons from the front lines

Chairs: D Nair, J Chun

14:30 Beyond pulmonary vein isolation: is pulsed field ablation the game-changer for adjunctive strategies? - S Tzeis

14:38 Mapping in pulsed field ablation: when is it essential and when is it not? -  P Sommer

14:46 Pulsed field ablation in redo procedures: durability, failures, and long-term data -  C Tondo

14:54 Ventricular pulsed field ablation: a new frontier - P Peichl

15:02 Conscious sedation or general anaesthesia for pulsed field ablation? practical evidence and workflow - 

J Garcia Bolao

15:10 Combining pulsed field ablation with left atrial appendage closure: a safe and strategic approach? -  O Wazni

15:18 Round table: pulsed field ablation in the lab

 

Session 3: Live cases: cutting-edge pulsed field ablation!

Chairs: J Vogler, D Gupta

Facilitator: D Scherr

15:45 Live case transmission from hospital: atrial fibrillation ablation and close - B Schmidt

16:00 Live case transmission from hospital:: ventricle pulsed field ablation - A Sarkozy

16:15 Live-in-the-Box: mapping pulmonary vein isolation - J OscaAsensi

16:25 Live-in-the-Box: mapping left atrium - JP Albenque

16:35 Live-in-the-Box: dual energy pulmonary vein isolation - T De Potter

 

Session 4: Latest science pulsed field ablation

Chairs: I Deisenhofer, D Della Rocca 

*Please note that this programme may still be subject to changes.